Tylenol questioned about Meltaway packs

The Maryland Poison Center has warned that the packaging and label copy of a new form of Children’s Tylenol could confuse parents and even medical professionals to accidentally offer a double dose that could cause liver damage.

The issue concerns the 80-mg form of Meltaways, a flavored, chewable form for children, ages two to six, packed in blister packs. While some blister packs contain one tablet, correctly labeled 80 mg, others also labeled 80 mg contain two 80-mg tablets, or a double dose.

“The parent doesn’t know if she should use the one tablet or the two that seem to be made to be given together,” said Dr. Suzanne Doyon, medical director at the center. Although there are no known children harmed

Conveying Innovations Report
Editors report on distinguishing characteristics that define each new product and collected video demonstrating the equipment or materials as displayed at the show. This topical report, winnowed from nearly 300 PACK EXPO collective booth visits, represents a categorized, organized account of individual items that were selected based on whether they were deemed to be both new, and truly innovative, based on decades of combined editorial experience in experiencing and evaluating PACK EXPO products.
Take me there
Conveying Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report